Annual report pursuant to Section 13 and 15(d)

Financial Instruments - Additional Information (Details)

v3.22.0.1
Financial Instruments - Additional Information (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 08, 2021
Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration (Note 3) $ 2,700   $ 0
Company X | Contingent Consideration - Company X      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Contingent consideration (Note 3)   $ 3,000